Dasatinib combined with docetaxel for castration-resistant prostate cancer : Results from a phase 1-2 study
John C. Araujo, Paul Mathew, Andrew J. Armstrong, Edward L. Braud, Edwin Posadas, Mathew Lonberg, Gary E. Gallick, Géralyn C. Trudel, Prashni Paliwal, Shruti Agrawal, Christopher J. LogothetisVolume:
118
Année:
2012
Langue:
english
Pages:
9
DOI:
10.1002/cncr.26204
Fichier:
PDF, 182 KB
english, 2012